Growing community of inventors

Sudbury, MA, United States of America

Hedy Adari-Hall

Average Co-Inventor Count = 6.86

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 18

Hedy Adari-HallZachary Shriver (8 patents)Hedy Adari-HallKarthik Viswanathan (8 patents)Hedy Adari-HallJames R Myette (8 patents)Hedy Adari-HallBoopathy Ramakrishnan (8 patents)Hedy Adari-HallAndrew M Wollacott (7 patents)Hedy Adari-HallGregory Babcock (6 patents)Hedy Adari-HallBharat Chaganty (2 patents)Hedy Adari-HallZachary Holmes Shriver (0 patent)Hedy Adari-HallHedy Adari-Hall (8 patents)Zachary ShriverZachary Shriver (85 patents)Karthik ViswanathanKarthik Viswanathan (40 patents)James R MyetteJames R Myette (28 patents)Boopathy RamakrishnanBoopathy Ramakrishnan (21 patents)Andrew M WollacottAndrew M Wollacott (18 patents)Gregory BabcockGregory Babcock (33 patents)Bharat ChagantyBharat Chaganty (2 patents)Zachary Holmes ShriverZachary Holmes Shriver (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Visterra, Inc. (8 from 37 patents)


8 patents:

1. 12338291 - Humanized antibody molecules to CD138 and uses thereof

2. 12091451 - Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)

3. 11945868 - Antibody molecules to CD138 and uses thereof

4. 11136385 - Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule

5. 10981982 - Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)

6. 10968270 - Antibody molecules to a proliferation-inducing ligand (APRIL)

7. 10954296 - Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA

8. 10385123 - Antibody molecules to a proliferation-inducing ligand (APRIL)

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…